(PRWEB) September 06, 2011
Revenues from all the products related to cataract surgery are expected to reach nearly $5 billion in 2011, and Market Scope forecasts that, buoyed by new technologies in this dynamic market, these revenues will increase more than twice as fast as cataract surgeries over the next five years. Premium intraocular lenses (IOLs) introduced during the past decade and those still in the pipeline are raising patient’s post-cataract visual expectations, just as the new laser-assisted cataract surgery technology is gaining interest and advocates with the promise of improved surgical precision.
Market Scope’s up-to-date and data-packed suite of 2011 reports includes three comprehensive global reports—on markets for IOLs, cataract surgical equipment, and single-use ophthalmic devices. Other cataract reports include the latest results from our annual survey of US cataract surgeons, a survey we have conducted for 10 years, and our US Cataract Market Quarterly Updates based on our quarterly surveys of US cataract surgeons. Market Scope has also recently published the US Cataract Atlas, a compendium of information and maps on 80 key metro areas featuring estimates of cataract, RLE, and premium lens procedures; population analysis by age and income levels; and market data for each metro area.
Cataract surgical technology is evolving rapidly at a time when the elderly population segment is soaring, life expectancies are climbing, and extended careers are becoming the norm. As a result, growing needs and expectations for good vision in all ranges have created significant new market opportunities, expanding demand for multifocal and accommodating IOLs designed to correct presbyopia, aspheric optics that address spherical aberration and make vision sharper, and phakic IOLs allowing treatment of extreme refractive error.
Ultrasonic phacoemulsification, the standard of care in cataract removal equipment for four decades, has been in great part responsible for the safety and effectiveness of modern cataract surgery and is certain to remain the dominant lens removal technology in the near future. However, a technology still in its infancy, laser-assisted cataract surgery using femtosecond lasers and picosecond lasers, promises to raise the standard of precision and safety to new heights.
Disposable surgical devices—viscoelastics, balanced salt solutions, disposable knives and instruments, etc.— also continue their healthy growth in the marketplace, spurred by the aging of the world’s population, the need for labor-saving devices to reduce costs in tight economic conditions, and increasing concerns over cross-contamination with reusable devices.
Market Scope’s suite of cataract surgery market reports gives the enormous global cataract surgery market unmatched visibility and transparency. Reports include detailed discussions of the epidemiology of cataracts; demographic trends; commercialized products and pipeline technologies; market drivers; and marketplace competitors such as Alcon, Abbott Medical Optics, Bausch & Lomb, Hoya, and Carl Zeiss, as well as smaller manufacturers. Market Scope analyzes procedure volume, units, prices, market share, and revenues, and forecasts performance in various market segments over the next five years using eight global categories organized by region and economic status.
For report descriptions and tables of contents, please follow these links:
2011 Comprehensive Report on the Global IOL Market
2011 Comprehensive Report on the Global Cataract Surgical Equipment Market
2011 Comprehensive Report on the Global Single-Use Surgical Device Market
2011 Annual Survey of US Cataract Surgeons
US Cataract Market Quarterly Updates
2011 US Cataract Atlas
Contact Katie Cannady for more information or to purchase these and/or other Market Scope reports. Visit http://www.market-scope.com online or call (314) 835-0600.
About Market Scope
Market Scope is recognized as the leading source for accurate and timely information on the ophthalmic industry. We have been conducting primary research, surveying ophthalmologists, and producing comprehensive reports on ophthalmic markets since 1996. Our data, analysis, and forecasts serve as starting points for many annual planning cycles, strategic plans, acquisition analyses, and return on investment decisions in the industry. In addition, our information is routinely included in annual reports, SEC filings, and investor presentations by leading ophthalmic companies.